Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
IMMUNOGENICS, LLC
🇺🇸
United States
Country
🇺🇸
United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Latiglutenase as a Treatment for Celiac Disease
Phase 2
Completed
Conditions
Celiac Disease
Interventions
Drug: Latiglutenase
Other: Placebo
Subscribe
First Posted Date
2018-07-13
Last Posted Date
2021-12-15
Lead Sponsor
Immunogenics, LLC
Target Recruit Count
79
Registration Number
NCT03585478
Locations
🇺🇸
Mayo Clinic - 200 First Street SW, Rochester, Minnesota, United States
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy